Pain Control in Renal Colic
- Registration Number
- NCT00646061
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
Renal colic is very common in emergency department patients. Our aim of this study is which combination of drug is more effective in renal colic.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- adult, clinical suspicion of renal colic
Exclusion Criteria
- under 15
- do not consent
- contraindication of morphine, ketorolac, or buscopan
- previously pain controlled
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description 1 buscopan morphine, ketorolac, and buscopan
- Primary Outcome Measures
Name Time Method pain control
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What is the molecular mechanism of buscopan in managing renal colic pain?
How does buscopan compare to NSAIDs in acute renal colic treatment efficacy?
Are there specific biomarkers that predict response to antispasmodic agents in renal colic?
What adverse events are associated with buscopan use in emergency department settings?
What combination therapies are being explored for renal colic beyond antispasmodic agents?
Trial Locations
- Locations (1)
Seoul National University Bundang Hospital
🇰🇷Seongnam-si, Kyeongi-do, Korea, Republic of
Seoul National University Bundang Hospital🇰🇷Seongnam-si, Kyeongi-do, Korea, Republic of